v3.25.1
BASIS OF FINANCIAL STATEMENT PRESENTATION (Details)
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Disaggregation of Revenue [Line Items]    
Percent of Revenue Contributed 100.00% 100.00%
Ownership percentage below which investments are generally accounted for on the cost method (in thousandths) 20.00%  
LabCorp Diagnostics [Member]    
Disaggregation of Revenue [Line Items]    
Percent of Revenue Contributed   78.00%
Biopharma Laboratory Services    
Disaggregation of Revenue [Line Items]    
Percent of Revenue Contributed 22.00% 22.00%